General Information of the Compound
Compound ID |
CP0213459
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-(1H-imidazol-4-yl)propylphenylmethyl ether
Show/Hide
|
||||||||||||||||||
Synonyms |
1H-Imidazole, 5-[3-(phenylmethoxy)propyl]-
3-(1H-imidazol-4-yl)propylphenylmethyl ether
4-(3-Benzyloxypropyl)-1H-imidazole
4-[3-(phenylmethoxy)propyl]-3H-imidazole
5-(3-phenylmethoxypropyl)-1H-imidazole
5-[3-(benzyloxy)propyl]-1H-imidazole
AC1O4XL1
BDBM22915
CHEBI:93359
CHEMBL19173
GTPL1255
NCGC00159580-01
Proxyfan
SCHEMBL15929504
SCHEMBL4072620
WNWALBVQAAIULR-UHFFFAOYSA-N
ZINC13813304
proxifan
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C13H16N2O
|
||||||||||||||||||
Molecular Weight |
216.284
|
||||||||||||||||||
Canonical SMILES |
C(COCc1ccccc1)Cc1cnc[nH]1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C13H16N2O/c1-2-5-12(6-3-1)10-16-8-4-7-13-9-14-11-15-13/h1-3,5-6,9,11H,4,7-8,10H2,(H,14,15)
Show/Hide
|
||||||||||||||||||
InChIKey |
WNWALBVQAAIULR-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Protein ID: PT01173, Histamine H3 receptor
Protein ID: PT01711, Histamine H4 receptor
Clinical Information about the Compound